From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.47
First Reported 1993
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 5
Total Number 5
Disease Relevance 3.89
Pain Relevance 0.57

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

nucleoplasm (ATM) signal transduction (ATM) cell death (ATM)
cytoplasmic membrane-bounded vesicle (ATM) nucleus (ATM) DNA binding (ATM)
ATM (Homo sapiens)
Pain Link Frequency Relevance Heat
cva 31 100.00 Very High Very High Very High
cINOD 3 91.44 High High
palliative 1 74.08 Quite High
aspirin 5 61.72 Quite High
halothane 1 40.88 Quite Low
withdrawal 8 5.00 Very Low Very Low Very Low
imagery 6 5.00 Very Low Very Low Very Low
agonist 3 5.00 Very Low Very Low Very Low
antagonist 2 5.00 Very Low Very Low Very Low
fibrosis 2 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Thyroid Neoplasm 169 100.00 Very High Very High Very High
Thrombosis 23 100.00 Very High Very High Very High
Lymphatic System Cancer 2 94.48 High High
Hemorrhage 16 94.16 High High
Carcinoma 27 91.88 High High
Sprains And Strains 165 90.88 High High
Thrombosis Related Under Development 7 89.84 High High
Cancer 78 82.44 Quite High
Necrosis 1 80.32 Quite High
Cv General 4 Under Development 1 76.96 Quite High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Combining the data on competition, pFRET and ATA effect, we suggest that the ATA sensitive anti-Leu8 and resistant anti-LAM1-3 bind to overlapping but non-identical epitopes.
ATA Binding (bind) of
1) Confidence 0.47 Published 1993 Journal Mol. Immunol. Section Abstract Doc Link 7505884 Disease Relevance 0.07 Pain Relevance 0.09
-act cga gcg gtt ttt ctt aac atc-3?
atc Binding (act) of
2) Confidence 0.36 Published 2010 Journal The Journal of Biological Chemistry Section Body Doc Link PMC2898415 Disease Relevance 0 Pain Relevance 0
Management of ATC
ATC Binding (Management) of associated with thyroid neoplasm
3) Confidence 0.10 Published 2010 Journal Journal of Thyroid Research Section Body Doc Link PMC2956973 Disease Relevance 1.88 Pain Relevance 0.07
ctr, ate, iso1, iso10) and genotypic (k?
ate Binding (genotypic) of
4) Confidence 0.07 Published 2009 Journal PLoS ONE Section Body Doc Link PMC2722085 Disease Relevance 0.56 Pain Relevance 0
As physicians gain more experience with bevacizumab and become familiar with patient selection, the risk of ATE associated with bevacizumab appears to decline.
ATE Binding (associated) of associated with cva
5) Confidence 0.06 Published 2009 Journal OncoTargets and therapy Section Body Doc Link PMC2886334 Disease Relevance 1.38 Pain Relevance 0.40

General Comments

This test has worked.

Personal tools